Supermodel challenges stroke stereotypes in new PSA campaign
October 31, 2014 06:00 ET
|
American Heart Association/American Stroke Association
Dallas, Oct. 31, 2014 (GLOBE NEWSWIRE) -- Supermodel Claudia Mason doesn't look like most people's image
of someone who has had a stroke, and that's exactly the point of
her new print PSA campaign...
VG Life Sciences' Advisor Gives Preeclampsia Presentation at American Heart Association Conference
September 12, 2014 08:42 ET
|
VG Life Sciences
SANTA BARBARA, Calif., Sept. 12, 2014 (GLOBE NEWSWIRE) -- VG Life Sciences, (OTC Pink:VGLS) a biotechnology company, announces that one of its scientific advisors, Dr. Brett Mitchell, PhD, will give...
National Institutes of Health and Mesoblast Enter Into Agreement for 120-Patient Trial In End-Stage Heart Failure
August 06, 2014 20:57 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today announced the signing of an agreement with the United...
Improved Outcomes Using Mesoblast Cells in End-Stage Heart Failure
June 24, 2014 21:19 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, June 24, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB, USOTC: MBLTY) today announced that trial results evaluating a low dose...
Lenox Hill Hospital Honored by American Heart Association with Quality Achievement Award For Treatment of Severe Heart Attack Patients
June 13, 2014 13:26 ET
|
North Shore Long Island Jewish Health System
NEW YORK, June 13, 2014 (GLOBE NEWSWIRE) -- Lenox Hill Hospital announced today that it has received the American Heart Association's bronze quality achievement award for implementing specific quality...
Mesoblast's Cell Therapy Strengthens Native Heart Function In Patients With End-Stage Heart Failure on Assisted Circulatory Support
November 18, 2013 18:14 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 18, 2013 (GLOBE NEWSWIRE) -- Patients with end-stage or New York Heart Association (NYHA) class IV heart failure who receive a surgically implanted left...
Aegerion Pharmaceuticals Presents Data From Phase 3 Extension Study of JUXTAPID(TM) (lomitapide) Capsules in Homozygous Familial Hypercholesterolemia (HoFH) at AHA Scientific Sessions
November 18, 2013 16:00 ET
|
Aegerion Pharmaceuticals, Inc.
CAMBRIDGE, Mass., Nov. 18, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of novel, life-altering...
Retailer Declares June as Stress-Free America Month; Organizes Protests Around Country
May 13, 2013 08:03 ET
|
Flip Flop Shops
ATLANTA, May 13, 2013 (GLOBE NEWSWIRE) -- As evidence mounts supporting a link between stress, heart disease and a slew of other ailments, national footwear retailer Flip Flop Shops has stepped up to...
Close Call at Age 38: Footwear Chain President Launches Heart Disease Prevention Campaign
February 25, 2013 09:03 ET
|
Flip Flop Shops
ATLANTA, Feb. 25, 2013 (GLOBE NEWSWIRE) -- Moving at rocket speed to launch multiple businesses and rise to the top of new industries almost cost Flip Flop Shops President & Co-Founder Brian Curin his...
Master Lock(R) Invites Consumers to 'Lock Up Love' and Enter to Win a Trip to Paris
February 04, 2013 08:00 ET
|
Master Lock
MILWAUKEE, WI--(Marketwire - Feb 4, 2013) - To raise awareness for American Heart Month, Master Lock is offering consumers the chance to win a trip to Paris, France through their MasterLoveLock.com...